The NFL Puts Together Winning Game Plan Against Prostate Cancer
Prostate cancer is the second most common cancer in men. On any given Sunday 1 in 7 men watching an NFL game will be diagnosed with this disease, but the odds increase to 1 in 5 if they are African American and 1 in 3 if they have a family history. These are stats that no one wants to see up on a scoreboard.
An estimated 181,000 new cases will be diagnosed in 2016 – that’s one father, brother or loved one being told every three minutes that they have prostate cancer. Prostate cancer is also the second leading cause of cancer-related death among men, and there are often no symptoms.
Early detection for prostate cancer is key, which is why, for the eighth year, the National Football League has teamed up with the Urology Care Foundation—the official foundation of the American Urological Association—on the Know Your Stats About Prostate Cancer® campaign, an initiative to encourage men to know their prostate cancer risk and to talk to their doctor about whether prostate cancer testing is right for them. The campaign is led by Pro Football Hall of Famer and prostate cancer survivor, Michael Haynes.
About Michael Haynes: Michael is a former National Football League cornerback who played for the New England Patriots and the Los Angeles Raiders. His professional football career began when he was selected in the 1976 NFL Draft by the New England Patriots. He is elected to the Pro Football Hall of Fame in 1997. Haynes, a prostate cancer survivor, is the spokesperson for the Know Your Stats About Prostate Cancer® campaign and speaks on their behalf to educate and encourage men to be proactive about their prostate health.
About Benjamin Lowentritt, M.D.: Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot assisted surgery for bladder cancer. He has authored numerous articles and chapters on subjects including robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.
Dr. Lowentritt has been selected as a "Super Doctor" by his peers in The Washington Post magazine and as a "Top Doctor" in Baltimore magazine. Dr. Lowentritt serves on the Board of Directors for the Baltimore City Medical Society.